NASA will begin testing Variable's E-Nose COVID-19 screening device, a handheld device that is designed to detect signature volatile organic compounds in the breath of people who have been infected with SARS-CoV-2. "Once the clinical trials are completed and the sensitivity and specificity are demonstrated, E-Nose can be deployed in factories, airports, grocery stores, and businesses of all sorts to rapidly screen for active infections," said Jing Li, the NASA scientist who invented the nanosensor technology used by the device.
NASA starts testing breath-based COVID-19 screening device
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.